Factor IX gene therapy (Sangamo Therapeutics)

N/A

Report date: 2025/01/26 18:04:45

Base Information

Drug NameFactor IX gene therapy (Sangamo Therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSangamo Therapeutics France Sas
China Registration ClassN/A

Develop Information

Active CompaniesSangamo Therapeutics France Sas
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A